HOME >> BIOLOGY >> NEWS
From nanotechnology to raspberries, Virginia Tech inventions and creations can improve our lives

craft are equipped with redundant control surfaces to enhance maneuvering capability. It is important to find the most effective combinations of these surfaces so that the aircraft is not carrying unnecessary weight and complex hydraulic systems, which detracts from its performance. It is also important that the optimal combinations be calculated in real-time so that the fly-by-wire control system can adapt to control system damage and failures while in flight. Durham's patented method has been exhaustively tested in Virginia Tech's manned-flight simulator, and demonstrates clear advantages over other methods used to distribute the control efforts.

Seshu Desu, a former professor of electrical engineering and materials science and engineering, and John Senkevich, a former student, invented a "Near-Room Temperature Thermal Chemical Vapor Deposition of Oxide Films" (Patent No. 6,316,055), which has been licensed to Quester Technologies Inc. This invention discloses methods for depositing SiO2 and other oxide dielectric materials using a near room temperature thermal chemical vapor deposition process. The films have chemical, physical, optical, and electrical properties similar to or better than those of oxide films deposited using conventional, high temperature methods. The films of the invention are useful in the manufacture of semiconductor devices of sub-micron feature size and for food packaging.

Life sciences

Thomas J. Inzana, professor of biomedical sciences and pathobiology in the Virginia-Maryland College of Veterinary Medicine at Virginia Tech, and former graduate student Christine Ward received a patent for "Recombinant Vaccine for Diseases Caused by Encapsulated Organisms" (No. 6,326,001), which has been licensed to American Home Products (now Wyeth Home Products). The patent is for vaccines to prevent diseases caused by normally encapsulated organisms. The vaccines are produced by genetically modifying key genes that encode for c
'"/>

Contact: Mike Martin
lucasd@vt.edu
540-951-9376
Virginia Tech
26-Apr-2002


Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. AACR applauds NCI initiative on nanotechnology
2. Researchers show how to assemble building blocks for nanotechnology
3. New textbook introduces students to the foundations, applications of nanotechnology
4. The future of nanotechnology
5. Researchers probe link between nanotechnology and health
6. Gulf between rich, poor will grow if high-profile nanotechnology opponents prevail: ethics experts
7. Intel and Fred Hutchinson to explore the use of nanotechnology tools for early disease detection
8. Integration of nanotechnology with biology and medicine will result in major medical advances
9. Rice University announces nanotechnology research agreement with IBM
10. Rice center to study therapeutic and environmental imapct of nanotechnology
11. UW, PNNL think big, aim small with creation of joint nanotechnology institute

Post Your Comments:
(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
(Date:11/21/2014)... JOSE, Calif. , Nov. 20, 2014   ... global leader in microcontroller (MCU) and touch technology solutions, ... digital temperature sensors with the widest V cc ... delivers higher temperature accuracy and faster I 2 C ... registers and serial EEPROM memory making them ideal for ...
(Date:11/18/2014)... YORK , Nov. 18, 2014   ... identity authentication solutions, and MorphoTrust USA ... and services, today announced a strategic partnership to ... enterprise, motor vehicle administration (MVA), airport screening and ... in identity-related solutions, MorphoTrust serves consumers through a ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
(Date:12/17/2014)... Ipsen Biopharmaceuticals, Inc., an affiliate ... IPSEY), today announced that Somatuline® Depot® (lanreotide) ... approved by the U.S. Food and Drug Administration ... (GEP-NETs) in adult patients with unresectable, well or ... improve progression-free survival (PFS). , “The approval of ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/17/2014)... 17, 2014 Tigercat Pharma, Inc. today ... evaluating the investigational oral NK-1 receptor antagonist VPD-737 ... chronic itch who are unresponsive or inadequately responsive ... steroids and antihistamines. The primary ... Scale (VAS) itch score from baseline, comparing drug ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
Cached News: